Negative FX effects and vitamin price volatility impact profit outlook
Dsm-firmenich expects 90 million euro FX cost in 2025
ANH unit separation seen as value catalyst by analysts
Adds CFO quote paragraphs 4 and 5, CEO quote paragraph 7, broker quote paragraph 9, details throughout
By Dimitri Rhodes
Oct 30 (Reuters) - European chemicals maker dsm-firmenich DSFIR.AS lowered its 2025 adjusted core profit guidance on Thursday, citing negative foreign exchange effects and volatility in vitamin prices.
The group expects adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to total 2.3 billion euros ($2.68 billion), down from the 2.4 billion euros previously guided, and slightly below the 2.32 billion euros expected by analysts in a company-compiled consensus.
Dsm-firmenich, whose products are used in perfumes made by French luxury groups LVMH LVMH.PA and Kering PRTP.PA, said it expects to book a 90 million euro cost from adverse exchange rates and 50 million euros from volatile vitamin costs in 2025.
"FX swings are obviously linked to the dollar, and a bit on the Swiss (franc)," finance chief Ralf Schmeitz said on an analyst call.
"Now the spread has widened, which is causing that adverse effect," he added.
Dsm‑firmenich reports in euros but earns and spends across currencies. In 2025, the euro value of dollar revenues fell while Swiss‑franc costs stayed relatively strong. When key currencies move away from each other, converting back to euros can hurt profits even if the underlying business is fine.
"The current volatility with customers temporarily deferring vitamin orders and anticipating lower prices also means that we expect a negative 25 million (euros) effect from vitamins in Q4" CEO Dimitri de Vreeze told analysts.
While sharpening focus on perfumes and flavours, the group said in February 2024 it planned to carve out its Animal Nutrition and Health (ANH) unit by the end of this year. That would lower its exposure to vitamins earnings volatility and reduce its capital intensity in line with its long-term strategy, it said at the time.
"We continue to believe that the upcoming separation of the ANH business can be a catalyst to unlock value," analysts at KBC published in a note to investors.
The company reported adjusted core profit of 540 million euros for the third quarter, in line with analysts' forecast.
($1 = 0.8575 euros)
Euro vs U.S. Dollar and Swiss franc in 2025 https://www.reuters.com/graphics/DSM%20FIRMENICH-RESULTS/mopabmzbgva/chart.png
(Reporting by Dimitri Rhodes; Editing by Mrigank Dhaniwala and Eileen Soreng)
((Dimitri.Rhodes@thomsonreuters.com;))